Surgery after targeted therapy or immunotherapy for metastatic kidney cancer
A recent retrospective study (looking back at the patients’ cases [...]
NHS England need for new diagnostic services
A report from NHS England has found that the COVID-19 [...]
Experimental Cancer Medicine Demystified, Cambridge
On Friday 27 September 2019, Sharon Kell attended the annual [...]
Cancer Research UK calls on government to address cancer inequality
A new report published today by Cancer Research UK highlights [...]
Managing the COVID-19 pandemic in the UK
In this video interview, Professor Thomas Powles, Director of London’s [...]
ESMO Virtual 2020: Quality of life impact of immune checkpoint inhibitors
Immune checkpoint inhibitors have changed the way renal cell carcinoma [...]
Burnout among cancer professionals during COVID-19
Two online surveys presented at the European Society of Medical [...]
Biomarkers for avelumab plus axitinib in advanced kidney cancer
The discovery of a reliable biomarker for how patients with [...]
The significance of body mass index (BMI) on kidney cancer outcomes
Being overweight or obese is a well-known risk factor for [...]
Triggers for delayed treatment in patients with small renal masses undergoing active surveillance
Active surveillance is an acceptable management strategy for patients with [...]
